Abbott India Q1 Results FY26: Q1 PAT Rises 11.54% to ₹365.86 Crore; Revenue Up 11.60% YoY

Abbott India Q1 Results FY26: Abbott India posted its Q1 results on 12th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹11.54 crores against revenue of ₹1,738.35 crores. During Q1 FY26, the profit increase of the company was recorded at 11.54% YoY, and the revenue increase for the same period was 11.60%. 

Abbott India Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

Abbott India Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Abbott India clocked Q1 FY26 standalone revenue of ₹1,738.35 crores vs ₹1,557.61 crores. 
• On the profit front, Abbott India earned a standalone PAT of ₹365.86 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹328.01 crore. 
• Standalone PAT rose for the first quarter of FY26, was 11.54% YoY, and revenue increased by 11.60% YoY. 

Abbott India Share Price Performance

On the opening bell of 12th August 2025, the shares of Abbott India opened at ₹33,080.00 per share. However, the initial gains are wiped out as of now, and Abbott India shares are trading at ₹32,290.00 per share, lower than their opening price. 

Considering the long-term performance, Abbott India shares have yielded close to 19.68% returns in the past 1 year, and 5-year returns stand at 96.07%. Over the maximum timeframe, the Abbott India share provided 6,281.42% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Abbott India shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your research before investing in shares and other securities.

Recent Articles

HBL Engineering Q1 Results FY26: Q1 PAT Rises 78.87% to ₹143.27 Crore; Revenue Up 15.70% YoY

Fine Organic Q1 Results FY26: Q1 PAT Rose 7.04% to ₹117.10 Crore; Revenue Up 7.04% YoY

Eureka Forbes Q1 Results FY26: Q1 PAT Rises 20.32% to ₹38.68 Crore; Revenue Up 9.85% YoY

JM Financial Q1 Results FY26: Q1 PAT Rose 165.85% to ₹453.81 Crore; Revenue Up 3.18% YoY

IPCA Laboratories Q1 Results FY26: Q1 PAT Rises 21.31% to ₹233.21 Crore; Revenue Up 10.33% YoY